Emory University Amicus Therapeutics, Inc. Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $1.54 Million - $2.55 Million	-192,533 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $178,878 - $235,022	-16,321 Reduced 7.81%	192,533 $2.4 Million
Q1 2019 May 09, 2019	SELL	$10.04 - $13.92 $90,560 - $125,558	-9,020 Reduced 4.14%	208,854 $2.84 Million
Q4 2018 Feb 12, 2019	BUY	$8.38 - $13.44 $1.83 Million - $2.93 Million	217,874 New	217,874 $2.09 Million

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.